NIAGEN BIOSCIENCE, INC. Amortization of Debt Issuance Costs and Discounts
NIAGEN BIOSCIENCE, INC. (NAGE) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2021-03-12
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs and discounts for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs and discounts for fiscal 2019 was $846.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 |
| 2019-12-31 | $846.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |